Scientific Calendar Event



Description An ICTP-IAEA Virtual Meeting

In recent years, there has been an increase of therapeutic applications using radiopharmaceuticals. This workshop, which is intended for clinically qualified medical physicists with experience in radionuclide therapy, will provide the participants with a comprehensive review of the developments in the field of nuclear medicine image quantification and practical internal dosimetry.
 
The purpose of this workshop is to contribute to the knowledge of clinically qualified medical physicists in nuclear medicine by providing theoretical and practical tools for internal dosimetry. Molecular radiotherapy has demonstrated unique therapeutic advantages in the treatment of an increasing number of cancer types. Such treatments can deliver high absorbed doses to specific targets (tumour lesions) and healthy organs (organs at risk) and, thus, require a patient specific dose assessment. These calculations would help to optimize the amount of radioactivity to be administered and to reduce the risk of under- or over-dosing patients, otherwise observed when using empirical approaches to activity determination. As part of the selection, candidates will be requested to undertake a written test.

The workshop is under the umbrella of ICTP and IAEA and is expected to strengthen the knowledge of clinically qualified medical physicists working in nuclear medicine. The expected audience are clinically qualified medical physicists working in a hospital, with at least 5 years’ experience in the field of nuclear medicine medical physics including radionuclide therapy. 
 
Topics:
  • Introduction to radiopharmaceutical dosimetry and MIRD formalism
  • Time integrated activity coefficient calculation
  • Radiation transport and energy deposition
  • ICRP Internal dose coefficient for radiological protection
  • Y-90 microspheres dosimetry
  • Bone seeking radiopharmaceuticals (including Ra223 therapy)
  • Peptide receptor radionuclide therapy
  • I131 therapy
  • Radiation safety for staff and the public in therapeutic nuclear medicine

Lecturers:

M. BARDIES, Cancer Research Institute of Montpellier U1194 INSERM/ICM/Montpellier University, France
W. BOLCH, Advanced Laboratory for Radiation Dosimetry Studies, J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, USA
C. CHIESA, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
M. CREMONESI, Istituto Europeo di Oncologia, IRCCS, Milano, Italy
L. FERRER, ICO René Gauducheau, Saint Herblain, France
F. GIAMMARILE, IAEA, Austria
G. GLATTING, Abteilung für Nuklearmedizin | Medizinische Strahlenphysik, University Ulm, Ulm, Germany
R. HOBBS, Department of Radiation Oncology and Molecular Radiation Sciences Johns Hopkins Medical Institution, Baltimore, USA
M. LASSMANN, Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Austria
G. LORETI, IAEA, Austria
L. STRIGARI, Department of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
A. VERGARA-GIL, CRCT, Toulouse, France

Registration: There is no registration fee.
Go to day
  • Monday, 20 September 2021
    • 13:30 - 16:00
      • 13:30 Course Introduction 30'
        Speaker: Peter KNOLL (IAEA, Austria), Renato PADOVANI (ICTP, Trieste)
      • 14:00 Introduction to radiopharmaceutical dosimetry and MIRD formalism 1h0'
        Speaker: Manuel BARDIES (Cancer Research Institute of Montpellier, France)
      • 15:00 Gamma camera and SPECT imaging 1h0'
        Speaker: Peter KNOLL (IAEA, Austria)
  • Tuesday, 21 September 2021
    • 14:00 - 17:00
      • 14:00 Probe and non-imaging activity determination 1h0'
        Speaker: Carlo CHIESA (Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy)
      • 15:00 Time-integrated activity coefficient calculation 1h0'
        Speaker: Gerhard GLATTING (Ulm University, Germany)
      • 16:00 Radiation transport and energy deposition 1h0'
        Speaker: Manuel BARDIES (Cancer Research Institute of Montpellier, France)
  • Wednesday, 22 September 2021
    • 14:00 - 17:00
      • 14:00 Clinical Overview of radiopharmaceutical therapies: present and future 1h0'
        Speaker: Francesco GIAMMARILE (IAEA, Austria)
      • 15:00 Relevance and implementation of dosimetry in therapeutic nuclear medicine 1h0'
        Speaker: Manuel BARDIES (Cancer Research Institute of Montpellier, France)
      • 16:00 Dosimetric models (phantoms, organs at risk) 1h0'
        Speaker: Wesley BOLCH (University of Forida, USA)
  • Friday, 24 September 2021
    • 14:00 - 17:00
      • 14:00 Radiobiology in Nuclear Medicine 1h0'
        Speaker: Robert HOBBS (Johns Hopkins Medical Institution, Baltimore, USA)
      • 15:00 I131 therapy of benign thyroid diseases + practical examples 1h0'
        Speaker: Michael LASSMANN (University Hospital Würzburg, Germany)
      • 16:00 I131 in treatment of thyroid carcinoma & blood dosimetry + practical examples 1h0'
        Speaker: Michael LASSMANN (University Hospital Würzburg, Germany)
  • Monday, 27 September 2021
    • 14:00 - 16:00
      • 14:00 ICRP Internal dose coefficient for radiological protection 1h0'
        Speaker: Wesley BOLCH (University of Forida, USA)
      • 15:00 Bone seeking radiopharmaceuticals (including Ra223 therapy) 1h0'
        Speaker: Lidia STRIGARI (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy)
  • Tuesday, 28 September 2021
    • 14:00 - 18:00
      • 14:00 Y-90 microspheres dosimetry 1h0'
        Speaker: Carlo CHIESA (Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy)
      • 15:00 Y-90 microspheres dosimetry practical applications with Slicer 3h0'
        Speaker: Carlo CHIESA (Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy), Alex VERGARA-GIL (CRCT, Toulouse, France), Ludovic FERRER (ICO René Gauducheau, Saint Herblain, France)
  • Wednesday, 29 September 2021
    • 13:00 - 17:00
      • 13:00 Peptide receptor radionuclide therapy 1h0'
        Speaker: Marta CREMONESI (Istituto Europeo di Oncologia, IRCCS, Milano, Italy)
      • 14:00 Peptide receptor radionuclide therapy Slicer: practical session 3h0'
        Speaker: Alex VERGARA-GIL (CRCT, Toulouse, France), Ludovic FERRER (ICO René Gauducheau, Saint Herblain, France)
  • Thursday, 30 September 2021
    • 14:00 - 16:00
      • 14:00 Available software and web resources for internal dosimetry 1h0'
        Speaker: Ludovic FERRER (ICO René Gauducheau, Saint Herblain, France)
      • 15:00 Use of Monte Carlo in NM 1h0'
        Speaker: Manuel BARDIES (Cancer Research Institute of Montpellier, France)
  • Friday, 1 October 2021
    • 14:00 - 17:00
      • 14:00 Radiation safety for staff and the public in therapeutic NM 1h0'
        Speaker: Lidia STRIGARI (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy)
      • 15:00 IAEA activities in support to Medical Physics 1h0'
        Speaker: Giorgia LORETI (IAEA, Austria)
      • 16:00 Clinical and physical factors affecting the predictive power of dosimetry 1h0'
        Speaker: Peter KNOLL (IAEA, Austria), Renato PADOVANI (ICTP, Trieste), Manuel BARDIES (Cancer Research Institute of Montpellier, France), Carlo CHIESA (Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy), Gerhard GLATTING (Ulm University, Germany), Francesco GIAMMARILE (IAEA, Austria), Wesley BOLCH (University of Forida, USA), Alex VERGARA-GIL (CRCT, Toulouse, France)